Novo Nordisk has officially launched Ozempic in India for diabetes care. Here's how the injectable works, its dosage options, ...
NDTV Profit on MSN
Novo Nordisk bets on 'India-tailored pricing' with Ozempic launch for type-2 diabetes
With this launch, Ozempic now available in India as a once-weekly injectable formulation of semaglutide. It will be available in a pen format in 0.25 mg, 0.5 mg and 1 mg doses in the country.
The lawsuit challenges FDA decisions since 2000 that approved and loosened restrictions on abortion drugs like mifepristone, ...
Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results